Craigavon Area Hospital is a teaching hospital in Portadown, Craigavon, County Armagh, Northern Ireland. It serves an estimated 241,000 people from the boroughs/districts of Craigavon, Banbridge, Armagh and Dungannon–South Tyrone.

There are 450 beds in Craigavon Area Hospital.

During the past decade, Craigavon Area Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Craigavon Area Hospital" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Concept Medical Inc." with 1 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Craigavon Area Hospital" #1 collaborator was "Baylor College of Medicine" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator, "National Health and Medical Research Council, Australia" with 1 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Craigavon Area Hospital" are "Coronary Artery Disease" (3 trials), "Anemia" (2 trials), "Bleeding Disorder" (2 trials), "Coagulation Disorder" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Craigavon Area Hospital" in a lesser frequency.

Most popular intervention types in "Craigavon Area Hospital" are "Drug" (6 trials), "Device" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "XIENCE" (2 trials), "chlorambucil" (2 trials), "doxorubicin hydrochloride" (2 trials), "fludarabine phosphate" (2 trials) and "vincristine sulfate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Craigavon Area Hospital" are 12 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Craigavon Area Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Craigavon Area Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Craigavon Area Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".